유럽 연합 - 프랑스어 - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - agents antinéoplasiques - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

esteve pharmaceuticals gmbh - métildigoxine 0,1 mg - comprimé - 0,1 mg - métildigoxine 0.1 mg - metildigoxin

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - acétonide de triamcinolone 40 mg/ml - suspension injectable - 40 mg/ml - acétonide de triamcinolone 40 mg/ml - triamcinolone

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - triamcinoloni acetonidum - suspension injectable - triamcinoloni acetonidum 40 mg, polysorbatum 80, carmellosum natricum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, kalii chloridum corresp. kalium 0.39 mg, natrii chloridum, natrii acetas trihydricus, natrii citras dihydricus, natrii hydroxidum aut acidum hydrochloridum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 4.27 mg. - visualisation de la vitrectomie - synthetika

프랑스 - 프랑스어 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoires alcon - acétonide de triamcinolone - suspension - 40 mg - composition pour 1 ml de suspension injectable > acétonide de triamcinolone : 40 mg - ophtalmologie, anti-inflammatoires, corticostéroïdes

캐나다 - 프랑스어 - Health Canada

novartis pharmaceuticals canada inc - acétonide de triamcinolone - suspension - 40mg - acétonide de triamcinolone 40mg - corticosteroids

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - complexus toxini botulinici a et haemagglutinini - solution injectable - complexus toxini botulinici a et haemagglutinini 125 u., histidinum, saccharum, natrii chloridum corresp. natrium 2.156 mg, polysorbatum 80, acidum hydrochloricum q.s. ad ph pro vitro. - zur vorübergehenden verbesserung des erscheinungsbildes von mittelstarken bis starken glabellafalten beim stirnrunzeln bei erwachsenen patienten unter 65 jahren, wenn das ausmass dieser falten eine erhebliche psychische belastung für den patienten darstellt. - biotechnologika